Detalles de la búsqueda
1.
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.
Ann Rheum Dis
; 82(5): 601-610, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36787994
2.
Genome-wide investigation of persistence to treatment with methotrexate in early rheumatoid arthritis.
Rheumatology (Oxford)
; 2023 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37326842
3.
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset.
Ann Rheum Dis
; 81(8): 1085-1095, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470158
4.
Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
Br J Haematol
; 194(3): 568-579, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34109612
5.
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.
Ann Rheum Dis
; 80(8): 1086-1093, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33622688
6.
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype.
Rheumatology (Oxford)
; 60(2): 809-819, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32810256
7.
Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome.
Rheumatology (Oxford)
; 60(2): 837-848, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32889544
8.
Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders.
Acta Oncol
; 60(6): 771-778, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33793378
9.
Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome.
Acta Oncol
; 58(8): 1170-1177, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31131659
10.
Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
Ann Rheum Dis
; 77(5): 650-657, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29237621
11.
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.
Ann Rheum Dis
; 76(12): 2025-2030, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28822981
12.
Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.
Acta Oncol
; 56(4): 599-607, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28084866
13.
Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.
Acta Oncol
; 55(9-10): 1139-1144, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27196149
14.
Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
Semin Cancer Biol
; 24: 61-70, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24333759
15.
Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
Ann Rheum Dis
; 74(6): 1212-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24608401
16.
Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.
Ann Rheum Dis
; 79(2): 307-308, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31694814
17.
Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis.
Acta Oncol
; 58(11): 1655-1659, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31407922
18.
A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
Acta Oncol
; 53(5): 669-79, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24164103
19.
Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
Int J Cancer
; 132(6): 1429-38, 2013 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22886725
20.
Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.
Int J Cancer
; 132(11): 2659-66, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23160780